SCHEMBL24760553

SCHEMBL24760553

C=C(CCc1ccc(N)cc1)NCC

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GFER P55789 1/20 0.45
▸ PLAAT3 P53816 1/20 0.41
▸ PLAAT5 Q96KN8 1/20 0.41
▸ PLAAT2 Q9NWW9 1/20 0.41
▸ PLAAT4 Q9UL19 1/20 0.41
▸ MAOB P27338 4/20 0.39
▸ MAOA P21397 2/20 0.39
▸ ESRRG P62508 1/20 0.38
▸ ALDH1A1 P00352 2/20 0.36
▸ LMNA P02545 1/20 0.36
▸ CYP19A1 P11511 4/20 0.36
▸ CYP3A4 P08684 1/20 0.35
▸ TSHR P16473 1/20 0.35
▸ TDP1 Q9NUW8 1/20 0.35
▸ TAAR1 Q96RJ0 1/20 0.35
▸ PPIB P23284 1/20 0.35
▸ PPIA P62937 1/20 0.35
▸ PPID Q08752 1/20 0.35
▸ PPIG Q13427 1/20 0.35
▸ LOXL2 Q9Y4K0 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18657166 0.75 GFER (0.54) GFERMAOBMAOAALDH1A1CYP19A1
SCHEMBL5962 0.71 GFER (0.68) GFERMAOBMAOAALDH1A1CYP19A1
SCHEMBL20712855 0.70 GFER (0.48) GFERMAOBMAOAALDH1A1CYP19A1
SCHEMBL19088829 0.70 ESRRG (0.50) GFERMAOBMAOAESRRGALDH1A1
SCHEMBL160035 0.70 ESRRG (0.54) GFERESRRGALDH1A1TSHRPPIB
SCHEMBL160330 0.70 RAB9A (0.55) ESRRGALDH1A1LMNACYP3A4TDP1
SCHEMBL27576975 0.70 GFER (0.59) GFERMAOBMAOAESRRGALDH1A1
SCHEMBL29155827 0.69 GFER (0.65) GFERMAOBMAOAALDH1A1CYP19A1
SCHEMBL17751262 0.69 GFER (0.46) GFERPLAAT3PLAAT5PLAAT2PLAAT4
SCHEMBL15109535 0.69 HPGD (0.49) ALDH1A1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022262789-A1 ANTITUMOR COMPOUND AND USE THEREOF 明慧医药(杭州)有限公司 2022-12-22 — — WO disclosed
Send feedback